EMBC
EMBC
NASDAQ · Health Care

Embecta Corp

$4.42
+0.92 (+26.29%)
As of Aug 8, 10:18 PM ET ·
Financial Highlights (FY 2026)
Revenue
1.26B
Net Income
111.16M
Gross Margin
63.9%
Profit Margin
8.8%
Rev Growth
-1.5%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 63.9% 63.9% 33.7% 33.7%
Operating Margin 22.4% 20.2% 21.4% 22.2%
Profit Margin 8.8% 8.4% 16.0% 18.6%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 1.26B 1.28B 208.68M 156.81M
Gross Profit 803.90M 815.90M 70.24M 52.78M
Operating Income 282.11M 257.69M 44.63M 34.84M
Net Income 111.16M 101.54M 33.44M 29.22M
Gross Margin 63.9% 63.9% 33.7% 33.7%
Operating Margin 22.4% 20.2% 21.4% 22.2%
Profit Margin 8.8% 8.4% 16.0% 18.6%
Rev Growth -1.5% -1.5% -8.7% -9.7%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 220.14M 224.10M
Total Equity 442.01M 483.57M
D/E Ratio 0.50 0.46
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 329.51M 317.70M 58.64M 45.10M
Free Cash Flow 30.27M 26.47M